Scheme
BAN
ATC (Anatomical Therapeutic Chemical Classification)
B02BD03
CAS registry number (Chemical Abstracts Service)
0078690-39-8
Therapeutic Categories
Hemostatic agent
Blood coagulation factor substitute
Foreign Names
- Prothrombinkomplex human mit Faktor VIII-Inhibitor-Bypass-Ak (German)
- Complexe prothrombique active (French)
Generic Names
- Activated Prothrombin Complex (OS: BAN)
- Activated Prothrombin Complex Concentrate (IS)
- Anti-inhibitor Coagulant Complex (IS)
- Complejo coagulante antiinhibidor del factor VIII (IS)
- Facteurs de coagulation ayant une activité court-circuitant l'inhibiteur du facteur VIII (IS)
- Factor VIII Inhibitor Bypassing Fraction (IS)
- FEIBA (IS: Factor Eight Inhibitor Bypassing Activity)
- Human-Plasmaproteine mit Faktor VIII-Inhibitor-Bypass-Aktivität (IS)
Brand Names
- Feiba Immuno Tim 4
Adcock Ingram Critical Care, South Africa; Baxter, Spain - Feiba NF
Baxter, Switzerland - Feiba
Baxter, Austria; Baxter, Belgium; Baxter, Czech Republic; Baxter, Germany; Baxter, Denmark; Baxter, Spain; Baxter, Finland; Baxter, France; Baxter, United Kingdom; Baxter, Georgia; Baxter, Croatia (Hrvatska); Baxter, Hungary; Baxter, Lithuania; Baxter, Latvia; Baxter, Malta; Baxter, Serbia; Baxter, Sweden; Baxter, Slovakia; Baxter, United States; Baxter-A, Italy; Eczacibasi Baxter, Turkey; Teva, Israel - Haemoctin SDH
Biotest, Lithuania; Biotest, Latvia
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment